These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 33855021)

  • 1. NUCB1 Suppresses Growth and Shows Additive Effects With Gemcitabine in Pancreatic Ductal Adenocarcinoma via the Unfolded Protein Response.
    Hua YQ; Zhang K; Sheng J; Ning ZY; Li Y; Shi WD; Liu LM
    Front Cell Dev Biol; 2021; 9():641836. PubMed ID: 33855021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nucleobindin 1 controls the unfolded protein response by inhibiting ATF6 activation.
    Tsukumo Y; Tomida A; Kitahara O; Nakamura Y; Asada S; Mori K; Tsuruo T
    J Biol Chem; 2007 Oct; 282(40):29264-72. PubMed ID: 17686766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. UBL4A inhibits autophagy-mediated proliferation and metastasis of pancreatic ductal adenocarcinoma via targeting LAMP1.
    Chen H; Li L; Hu J; Zhao Z; Ji L; Cheng C; Zhang G; Zhang T; Li Y; Chen H; Pan S; Sun B
    J Exp Clin Cancer Res; 2019 Jul; 38(1):297. PubMed ID: 31288830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The m6A methyltransferase METTL16 inhibits the proliferation of pancreatic adenocarcinoma cancer cells
    Xie F; Zheng Y; Fu W; Chi B; Wang X; Zhang J; Gu J; Yin J; Zhou Q; Guo S; Cai L; Yang J; Liu S; Wang H
    Front Oncol; 2023; 13():1138238. PubMed ID: 37182151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Andrographis Reverses Gemcitabine Resistance through Regulation of ERBB3 and Calcium Signaling Pathway in Pancreatic Ductal Adenocarcinoma.
    Okuno K; Xu C; Pascual-Sabater S; Tokunaga M; Takayama T; Han H; Fillat C; Kinugasa Y; Goel A
    Biomedicines; 2023 Jan; 11(1):. PubMed ID: 36672630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of Wnt/β-catenin Signaling in PDAC via METTL16-mediated N6-methyladenosine Modification of DVL2.
    Yu L; Lu J; Xie N; Fang L; Chen S; Wu Y; Wang X; Li B
    J Cancer; 2023; 14(16):2964-2977. PubMed ID: 37859814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. YAP-LAMB3 axis dictates cellular resistance of pancreatic ductal adenocarcinoma cells to gemcitabine.
    Li Y; Wang X; Yu H; Cao J; Xie J; Zhou J; Feng Z; Chen W
    Mol Carcinog; 2024 Jul; ():. PubMed ID: 39016677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-410-3p attenuates gemcitabine resistance in pancreatic ductal adenocarcinoma by inhibiting HMGB1-mediated autophagy.
    Xiong J; Wang D; Wei A; Ke N; Wang Y; Tang J; He S; Hu W; Liu X
    Oncotarget; 2017 Dec; 8(64):107500-107512. PubMed ID: 29296182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of nucleobindin 1 (NUCB1) in pancreatic islets and other endocrine tissues.
    Williams P; Tulke S; Ilegems E; Berggren PO; Broberger C
    Cell Tissue Res; 2014 Nov; 358(2):331-42. PubMed ID: 25038744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of Notch3 links TIMP3 inhibition to suppress aggressive phenotypes of pancreatic ductal adenocarcinoma.
    Chiu TJ; Chen YJ; Lan J; Chen YY; Chen YC; Lin HW; Tsai HT; Lin YS; Hsiao CC; Chen CH
    Am J Cancer Res; 2021; 11(11):5609-5624. PubMed ID: 34873483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Emerging Role for the Unfolded Protein Response in Pancreatic Cancer.
    Robinson CM; Talty A; Logue SE; Mnich K; Gorman AM; Samali A
    Cancers (Basel); 2021 Jan; 13(2):. PubMed ID: 33445669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RACK1 overexpression associates with pancreatic ductal adenocarcinoma growth and poor prognosis.
    Li X; Xiao Y; Fan S; Xiao M; Wang X; Chen X; Li C; Zong G; Zhou G; Wan C
    Exp Mol Pathol; 2016 Oct; 101(2):176-186. PubMed ID: 27498047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gemcitabine enhances OSI-027 cytotoxicity by upregulation of miR-663a in pancreatic ductal adenocarcinoma cells.
    Huang B; Wang J; Chen Q; Qu C; Zhang J; Chen E; Zhang Y; Wang Y; Ni L; Liang T
    Am J Transl Res; 2019; 11(1):473-485. PubMed ID: 30788003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ARHGEF15 overexpression worsens the prognosis in patients with pancreatic ductal adenocarcinoma through enhancing the motility and proliferative activity of the cancer cells.
    Fukushima H; Yasumoto M; Ogasawara S; Akiba J; Kitasato Y; Nakayama M; Naito Y; Ishida Y; Okabe Y; Yasunaga M; Horiuchi H; Sakamoto E; Itadani H; Mizuarai S; Oie S; Yano H
    Mol Cancer; 2016 May; 15(1):32. PubMed ID: 27145964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulated Expression of TUBA1C Predicts Poor Prognosis and Promotes Oncogenesis in Pancreatic Ductal Adenocarcinoma via Regulating the Cell Cycle.
    Albahde MAH; Zhang P; Zhang Q; Li G; Wang W
    Front Oncol; 2020; 10():49. PubMed ID: 32117719
    [No Abstract]   [Full Text] [Related]  

  • 16. Nucleobindin 1 (NUCB1) is a Golgi-resident marker of neurons.
    Tulke S; Williams P; Hellysaz A; Ilegems E; Wendel M; Broberger C
    Neuroscience; 2016 Feb; 314():179-88. PubMed ID: 26666627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Down-regulation of miR-30a-5p is Associated with Poor Prognosis and Promotes Chemoresistance of Gemcitabine in Pancreatic Ductal Adenocarcinoma.
    Zhou L; Jia S; Ding G; Zhang M; Yu W; Wu Z; Cao L
    J Cancer; 2019; 10(21):5031-5040. PubMed ID: 31602254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COMMD7 functions as molecular target in pancreatic ductal adenocarcinoma.
    You N; Li J; Gong Z; Huang X; Wang W; Wang L; Wu K; Zheng L
    Mol Carcinog; 2017 Feb; 56(2):607-624. PubMed ID: 27350032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TGFB1-induced autophagy affects the pattern of pancreatic cancer progression in distinct ways depending on SMAD4 status.
    Liang C; Xu J; Meng Q; Zhang B; Liu J; Hua J; Zhang Y; Shi S; Yu X
    Autophagy; 2020 Mar; 16(3):486-500. PubMed ID: 31177911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. USP44 suppresses pancreatic cancer progression and overcomes gemcitabine resistance by deubiquitinating FBP1.
    Yang C; Zhu S; Yang H; Deng S; Fan P; Li M; Jin X
    Am J Cancer Res; 2019; 9(8):1722-1733. PubMed ID: 31497353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.